Arcutis Biotherapeutics Inc ARQT
NASDAQ · United States · Health Technology
$26.01-0.42 (-1.59%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-05 | 0.11 | 0.06 | +99.7% | $129.86M | +9.3% | +1.5%$26.03→$26.43 |
| Q1 2026 | 2026-05-06 | -0.09 | -0.02 | -350.0% | — | — | -11.8%$23.42→$20.66 |
| Q4 2025 | 2026-02-25 | 0.13 | 0.09 | +44.4% | — | — | +5.9%$26.98→$28.57 |
| Q3 2025 | 2025-10-28 | 0.06 | -0.09 | +166.7% | — | — | +28.8%$19.64→$25.29 |
| Q1 2025 | 2025-05-06 | -0.20 | -0.21 | +4.8% | — | — | — |
| Q4 2024 | 2025-02-25 | -0.09 | -0.26 | +65.4% | — | — | — |
| Q2 2024 | 2024-08-14 | -0.42 | -0.53 | +20.8% | — | — | — |
| Q1 2024 | 2024-05-14 | -0.32 | -0.73 | +56.2% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.